US20020001575A1 - Nutritional system for nervous system disorders - Google Patents

Nutritional system for nervous system disorders Download PDF

Info

Publication number
US20020001575A1
US20020001575A1 US09/865,040 US86504001A US2002001575A1 US 20020001575 A1 US20020001575 A1 US 20020001575A1 US 86504001 A US86504001 A US 86504001A US 2002001575 A1 US2002001575 A1 US 2002001575A1
Authority
US
United States
Prior art keywords
vitamin
mcg
root
nervous system
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/865,040
Other versions
US6399114B2 (en
Inventor
David Foreman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C&D FOREMAN Inc
Original Assignee
C&D FOREMAN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C&D FOREMAN Inc filed Critical C&D FOREMAN Inc
Priority to US09/865,040 priority Critical patent/US6399114B2/en
Assigned to C&D FOREMAN, INC. reassignment C&D FOREMAN, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FOREMAN, DAVID J.
Publication of US20020001575A1 publication Critical patent/US20020001575A1/en
Application granted granted Critical
Publication of US6399114B2 publication Critical patent/US6399114B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23001—Pepsin A (3.4.23.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention pertains to the field of nutritional formulas. Specifically, the present invention pertains to an improved formula for nervous system disorders.
  • disorders that affect the proper functioning of the nervous system include autism, ADD, ADHD, hyperactivity disorder, and depression. People who suffer from these disorders often have common secondary symptoms including allergies, sluggish digestion, weak immune function and poor diet.
  • Treatment for these various nervous system disorders include the use of synthetic drugs. Specifically, for ADD and ADHD mild central nervous system stimulant drugs such as Ritalin®, Cylert® and Dexedrine® have been used. These drugs are not always successful. Moreover, such drugs may lead to undesirable side effects such as loss of appetite, insomnia, headaches, stomachaches, drowsiness and cardiac arrhythmia.
  • the foregoing and additional objects are obtained by providing a novel composition for treating nervous system disorders.
  • the composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp.
  • Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.
  • the composition is formed by preparing a mixture comprising an effective amount of beta carotene, vitamin E, selenium, vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-1, vitamin B-2, niacinamide, vitamin B-12, zinc, copper, biotin, pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, betaine HCl, pancreatin, papain, and pepsin.
  • the effective range amount of each ingredient for sixty pounds of body weight is as follows: 1,250-25,000 IU beta carotene, 25-400 IU vitamin E, 25-100 mcg selenium, 100-500 mg vitamin B-6, 400-800 mcg folic acid, 250-1,000 mg vitamin C, 125-500 mg magnesium, 12.5-50 mg vitamin B-1, 12.5-50 mg vitamin B-2, 15-60 mg niacinamide, 12.5-50 mcg vitamin B-12, 8-50 mg zinc, 250-1,000 mcg copper, 25-100 mcg biotin, 12.5-50 mg pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg betaine HCl, 125-1,000 mg pancreatin, 50-250 mg papain, and (1:3000
  • the effective amount of each ingredient for sixty pounds of body weight is as follows: 5000 IU beta carotene, 50 IU vitamin E, 25 mcg selenium, 500 mg vitamin B-6, 400 mcg folic acid, 500 mg vitamin C, 250 mg magnesium, 25 mg vitamin B-1, 25 mg vitamin B-2, 30 mg niacinamide, 25 mcg vitamin B-12, 10 mg zinc, 500 mcg copper, 50 mcg biotin, 25 mg pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg betaine HCl, 250 mg pancreatin, 100 mg papain, and (1:3000) 30 mg pepsin.
  • composition of the present invention acts to assist in treatment of nervous system disorders.
  • the concept of the composition is to give the body the tools it needs to digest, absorb, manufacture and utilize nutrients that help in the formation of neurotransmitters. This composition has a balancing effect in the body.
  • the components may be mixed in any order to prepare the composition.
  • the composition may comprise the same components that were added to the mixture, or items from which the components may be derived.
  • the components of the composition are in a form that are systemically absorbable by a human.
  • the composition may be in tablet, capsule or powder form.
  • the powder can be mixed in water or other consumable liquid and may be flavored for taste.
  • Each capsule contains a unit dose of each component.
  • An effective dose is one capsule per approximate 10 pounds of body weight. Said dose is preferably taken divided among meals and snacks eaten during the day. For example, a 60 pound child would take 6 capsules daily—2 with breakfast, 2 with lunch, 2 with dinner.
  • a dose in powder form is one teaspoon per 20 pounds of body weight.
  • the components may be formulated for administration into one composition containing all the components.
  • the components may be formulated into more than one composition, each which contains one or more of the components.
  • each component may constitute a separate composition, and be administered separately. It is preferable to administer the smallest number of separate compositions. Yeast, wheat, corn and gluten products are avoided as fillers.
  • the foregoing and additional objects are obtained by providing a novel composition for treating nervous system disorders.
  • the composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke and kelp.
  • Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.
  • the composition is formed by preparing a mixture comprising an effective amount of beta carotene, vitamin E, selenium, vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-1, vitamin B-2, niacinamide, vitamin B-12, zinc, copper, biotin, pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, betaine HCl, pancreatin, papain, and pepsin.
  • the effective range amount of each ingredient for sixty pounds of body weight is as follows: 1,250-25,000 IU beta carotene, 25-400 IU vitamin E, 25-100 mcg selenium, 100-500 mg vitamin B-6, 400-800 mcg folic acid, 250-1,000 mg vitamin C, 125-500 mg magnesium, 12.5-50 mg vitamin B-1, 12.5-50 mg vitamin B-2, 15-60 mg niacinamide, 12.5-50 mcg vitamin B-12, 8-50 mg zinc, 250-1,000 mcg copper, 25-100 mcg biotin, 12.5-50 mg pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg betaine HCl, 125-1,000 mg pancreatin, 50-250 mg papain, and (1:3000
  • the effective amount of each ingredient for sixty pounds of body weight is as follows: 5000 IU beta carotene, 50 IU vitamin E, 25 mcg selenium, 500 mg vitamin B-6, 400 mcg folic acid, 500 mg vitamin C, 250 mg magnesium, 25 mg vitamin B-1, 25 mg vitamin B-2, 30 mg niacinamide, 25 mcg vitamin B-12, 10 mg zinc, 500 mcg copper, 50 mcg biotin, 25 mg pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg betaine HCl, 250 mg pancreatin, 100 mg papain, and (1:3000) 30 mg pepsin.
  • Vitamin B-6 comprises a group of closely related compounds: pyridoxine, pyridoxal, and pyridoxamine. They are all phosphorylated in the body to pyridoxal phosphate, which functions as a coenzyme in many reactions. Vitamin B-6 helps to make and take apart many amino acids and is also needed to make serotonin, melatonin, and dopamine. Vitamin B-6 also aids in the formation of several neurotransmitters and is therefore an essential nutrient in the regulation of mental processes and possibly mood. Vitamin B-6 has been found to be helpful in almost half of all autistic children and adults included in 18 consecutive studies between 1965 and 1996.
  • B-6 is the preferred substance for this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of B-6 could be substituted.
  • Folic acid is needed to make SAMe (S-adenosyl-L-methionine), which affects and may improve mood.
  • SAMe S-adenosyl-L-methionine
  • Folate (folic acid) deficiency has been shown to lead to many conditions including psychiatric disorders. (Merck Manual 14th edition) Folic acid itself has been reported to be helpful in autism.
  • Folic Acid is the preferred substance for this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of Folic acid could be substituted.
  • Other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have
  • Vitamin C is crucial to brain function and has been known to improve cognition and emotional symptoms.
  • Vitamin C ascorbic acid
  • Vitamin C is the preferred substance for this formulation, however other items such as Capsicum, Rose Hips, Alfalfa, Asparagus root, Barberry bark, Bilberry fruit, Celery seed, Chaparral, Cranberry fruit, Echinacea, Goldenseal, Parsley, Hops, Horseradish, Mullein leaf, Nettle leaf, Papaya fruit, Peppermint, Red Clover, Red Raspberry, and Yellow Dock also have high concentrations of Vitamin C could be substituted.
  • Magnesium has been found to enhance the effects of B-6 and protect against possible magnesium deficiency from processed foods. Magnesium has been known to reduce hyperactivity in children. Other research suggests that some children with ADD have lowered levels of magnesium. Magnesium is the preferred substance for this formulation, however other items such as Althea root, Astragalus root, Bilberry fruit, Irish moss, Boneset, Bupleururn root, Burdock root, Catnip, Chamomile, Chickweed, Devil's Claw, Elecampane root, Fennel seed, Ginger root, Gotu Kola, Hibiscus flower, Horseradish root, Horsetail, Hydrangea root, Kelp, Licorice root, Nettle, Oatgrass, Parsley, Peppermint, Red Raspberry leaf, Siberian Ginseng, Spirulina, Turneric, White Willow bark, and Yerba Santa also have high concentrations of Magnesium could be substituted.
  • Vitamin B-3 comes in two basic forms—niacin (also called nicotinic acid) and niacinamide (also called nicotinamide).
  • the body uses B-3 in the process of releasing energy from carbohydrates. It is needed to form fat from carbohydrates and to process alcohol.
  • Deficiencies of B-3 include symptoms of organic psychosis, characterized by memory impairment, disorientation, confusion, excitement, depression and mania. It also can lead to encephalopathic syndrome, characterized by clouding of consciousness, rigidity of the extremities and uncontrollable sucking and grasping reflexes.
  • Niacinamide is the preferred substance for use in this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of niacin could be substituted.
  • Copper is essential as a catalyst in many of the enzymatic pathways in the body. It is also part of the antioxidant enzyme superoxide dismutase (SOD). Copper is needed to make adenosine triphosphate (ATP), the energy on which the body runs. Copper is the preferred substance for this formulation, however other items such as Scullcap, Sage, White oak bark, Horsetail, Brewer's yeast also have high concentrations of Copper could be substituted.
  • SOD superoxide dismutase
  • ATP adenosine triphosphate
  • Dandelion Root supports the digestive tract. It primarily works with the liver and gallbladder by stimulating digestive enzymes produced by each organ. It also stimulates digestion and can help with those who suffer from constipation and acid reflux. This herb is also high in many vitamins and minerals. Vitamins found in food are better absorbed and retained by the body. This is essential to the formulation by not only giving the digestive system support, but also by giving a natural source of vitamins and minerals. Dandelion is the preferred substance for use in this formulation, however other items such as Kelp, Sea Vegetation, Alfalfa, Trace Minerals, and Molybdenum, which also have high concentrations of minerals, could be substituted. As for digestive support, Dandelion is the preferred substance for use in this formulation, however other items such as Juniper, Aloe vera, Burdock, Ginger root, and Artichoke also have potent effects on supporting the digestive tract and could be substituted.
  • Probiotic (acidophilus dairy free/bifidus dairy free) bacteria favorably alter the intestinal micro-flora balance, inhibit the growth of harmful bacteria, promote good digestion, boost immune function, and increase resistance to infection. Individuals with flourishing intestinal colonies of beneficial bacteria are better equipped to fight the growth of disease-causing bacteria. Probiotics are important in finishing the digestive process and therefore can increase the absorption of nutrients.
  • Fructo-oligosaccharides are naturally occurring carbohydrates that cannot be digested or absorbed by humans but support the growth of bifidobacteria, one of the beneficial bacterial strains. Friendly bacteria support digestion, elimination and the absorption of nutrients in the body.
  • Betaine (hcl/gastric acid)
  • gastric (stomach) acid helps break down proteins for further digestion in the small intestine. This increased digestion aids in the absorption of nutrients that support the nervous system.
  • Papain/Pancreatin/Pepsin Digestive enzymes—also called pancreatic enzymes—include three classes of enzymes: proteolytic enzymes needed to digest protein, lipases needed to digest fat, and amylases needed to digest carbohydrates. Pancreatic enzymes should be used with to support the digestive process. Allergies are triggered by partially undigested protein, while protoolytic enzymes reduce allergy symptoms. Proteolytic enzymes such as trypsin, chymotrypsin, and bromelain are partially absorbed by the body. Proteolytic enzymes may improve immune system ftinction, a common problem with people with allergies and nervous system weakness. Papain, Pancreatin and, Pepsin are the preferred substance for this formulation, however other items such as Papaya, and Pineapple also have high concentrations of these digestive enzymes could be substituted.
  • Vitamin B-1 is needed to process carbohydrates, fat, and protein. Vitamin B-1 aids in the formation of ATP. Nerve cells require vitamin B-1 in order to function normally.
  • Vitamin B-2 is needed to process amino acids and fats, activate Vitamin B-6 and folic acid and help convert carbohydrates into ATP. Vitamin B-2 can also act as an antioxidant.
  • Vitamin B-12 is needed for normal nerve cell activity, DNA replication, and production of the mood-affecting substance SAMe (S-adenosyl-L-methionine). Vitamin B-12 acts with folic acid and vitamin B-6 to control homocysteine levels. An excess of homocysteine may increase the risk of heart disease, stroke, and perhaps osteoporosis and Alzheimer's disease.
  • SAMe S-adenosyl-L-methionine
  • Biotin a water-soluble B vitamin, acts as a coenzyme during the metabolism of protein, fats, and carbohydrates. Certain rare inborn diseases can leave people with depletion of biotin due to the inability to metabolize the vitamin normally.
  • Pantothenic acid sometimes called vitamin B-5, is involved in the Kreb's cycle of energy production and is needed to make the neurotransmitter acetylcholine. It is also essential in producing, transporting, and releasing energy from fats. Synthesis of cholesterol (needed for vitamin D and hormone synthesis) depends on pantothenic acid. Pantothenic acid also activates the adrenal glands. Pantethine—a variation of pantothenic acid—has been reported to lower blood levels of cholesterol and triglycerides.
  • Chromium Polynicotinate supports the balancing of blood sugar levels. Fast peaks and valley's of blood sugar have been linked to behavioral changes in humans. Chromium is the preferred substance for this formulation, however other items such as Hibiscus flower, Spirulina, Gymnema, Oatstraw, Nettle, Red Clover, Stevia, Barley Grass, Horseradish, Juniper, Pollen, Red Clover, Brewer's Yeast, Ginkgo, Catnip, also have high concentrations of Chromium could be substituted.
  • Beta-carotene (Vitamin A), by maintaining healthy cell membranes, helps prevent invasion by disease-causing microorganisms. Vitamin A also stimulates immunity and is needed for formation of bone, protein, and growth hormone. Beta-carotene is a substance from plants that the body can convert to vitamin A. There is research linking vitamin A deficiency to humans with Autism and other mental health and behavioral challenges.
  • Beta-carotene is the preferred substance for this formulation, however other items such as Spirulina, Carrot, Gotu Kola, cabbage, Barley grass, Peppermint, Yellow Dock, Parsley, Horseradish, Alfalfa, Chaparral, Capsicum, captivating Thistle, Nettle, Yerba santa, Dandelion and Stevia also have high concentrations of Beta-carotene (Vitamin A) could be substituted.
  • a sample composition, for a patient weighing sixty pounds, according to the present invention is set forth below: INGREDIENT AMOUNT Beta Carotene 5000 IU Vitamin E 50 IU Selenium 25 mcg Vitamin B-6 500 mg Folic Acid 400 mcg Vitamin C 500 mg Magnesium 250 mg Vitamin B-1 25 mg Vitamin B-2 25 mg Niacinamide 30 mg Vitamin B-12 25 mcg Zinc 10 mg Copper 500 mcg Biotin 50 mcg Pantothenic acid 25 mg Dandelion root 250 mg Acidophilus dairy free 500 million cfu bifidus dairy free 500 million cfu FOS powder 250 mg Chromium 100 mcg polynicotinate Betaine HCL 30 mg Pancreatin 250 mg Papain 100 mg Pepsin (1:3000) 30 mg

Abstract

A novel composition for treating nervous system disorders. The composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp. Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • The present application claims priority from U.S. Provisional Application Ser. No. 60/207,665, filed May 26, 2000.[0001]
    • BACKGROUND OF THE INVENTION
  • 1. Technical Field of the Invention [0002]
  • The present invention pertains to the field of nutritional formulas. Specifically, the present invention pertains to an improved formula for nervous system disorders. [0003]
  • 2. Discussion of the Related Art [0004]
  • There are many disorders that affect the proper functioning of the nervous system. Examples of these disorders include autism, ADD, ADHD, hyperactivity disorder, and depression. People who suffer from these disorders often have common secondary symptoms including allergies, sluggish digestion, weak immune function and poor diet. [0005]
  • Treatment for these various nervous system disorders include the use of synthetic drugs. Specifically, for ADD and ADHD mild central nervous system stimulant drugs such as Ritalin®, Cylert® and Dexedrine® have been used. These drugs are not always successful. Moreover, such drugs may lead to undesirable side effects such as loss of appetite, insomnia, headaches, stomachaches, drowsiness and cardiac arrhythmia. [0006]
  • There is, therefore, a need for new treatments of nervous system disorders that avoid the disadvantages of the known treatments. It is an objective of the present invention to provide such treatments. More specifically, it is an objective of the present invention to provide a new treatment for nervous system disorders, better than known methods, while at the same time avoiding the side effects observed with traditional drugs. Additional objects and advantages of the present invention are apparent from the specification which follow. [0007]
    • SUMMARY OF THE INVENTION
  • According to the present invention, the foregoing and additional objects are obtained by providing a novel composition for treating nervous system disorders. The composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp. Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum. [0008]
  • In a preferred embodiment, the composition is formed by preparing a mixture comprising an effective amount of beta carotene, vitamin E, selenium, vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-1, vitamin B-2, niacinamide, vitamin B-12, zinc, copper, biotin, pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, betaine HCl, pancreatin, papain, and pepsin. [0009]
  • The effective range amount of each ingredient for sixty pounds of body weight is as follows: 1,250-25,000 IU beta carotene, 25-400 IU vitamin E, 25-100 mcg selenium, 100-500 mg vitamin B-6, 400-800 mcg folic acid, 250-1,000 mg vitamin C, 125-500 mg magnesium, 12.5-50 mg vitamin B-1, 12.5-50 mg vitamin B-2, 15-60 mg niacinamide, 12.5-50 mcg vitamin B-12, 8-50 mg zinc, 250-1,000 mcg copper, 25-100 mcg biotin, 12.5-50 mg pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg betaine HCl, 125-1,000 mg pancreatin, 50-250 mg papain, and (1:3000) 15-100 mg pepsin. [0010]
  • In a preferred embodiment, the effective amount of each ingredient for sixty pounds of body weight is as follows: 5000 IU beta carotene, 50 IU vitamin E, 25 mcg selenium, 500 mg vitamin B-6, 400 mcg folic acid, 500 mg vitamin C, 250 mg magnesium, 25 mg vitamin B-1, 25 mg vitamin B-2, 30 mg niacinamide, 25 mcg vitamin B-12, 10 mg zinc, 500 mcg copper, 50 mcg biotin, 25 mg pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg betaine HCl, 250 mg pancreatin, 100 mg papain, and (1:3000) 30 mg pepsin. [0011]
    • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The composition of the present invention acts to assist in treatment of nervous system disorders. The concept of the composition is to give the body the tools it needs to digest, absorb, manufacture and utilize nutrients that help in the formation of neurotransmitters. This composition has a balancing effect in the body. [0012]
  • The components may be mixed in any order to prepare the composition. The composition may comprise the same components that were added to the mixture, or items from which the components may be derived. [0013]
  • The components of the composition are in a form that are systemically absorbable by a human. The composition may be in tablet, capsule or powder form. The powder can be mixed in water or other consumable liquid and may be flavored for taste. [0014]
  • Each capsule contains a unit dose of each component. An effective dose is one capsule per approximate 10 pounds of body weight. Said dose is preferably taken divided among meals and snacks eaten during the day. For example, a 60 pound child would take 6 capsules daily—2 with breakfast, 2 with lunch, 2 with dinner. A dose in powder form is one teaspoon per 20 pounds of body weight. [0015]
  • The components may be formulated for administration into one composition containing all the components. Alternatively, the components may be formulated into more than one composition, each which contains one or more of the components. In addition, each component may constitute a separate composition, and be administered separately. It is preferable to administer the smallest number of separate compositions. Yeast, wheat, corn and gluten products are avoided as fillers. [0016]
  • In the discussions below, all numbers are approximate, unless otherwise stated. MG stands for milligram, MCG stands for microgram and IU represents international units and CFU means colony forming units. [0017]
  • According to the present invention, the foregoing and additional objects are obtained by providing a novel composition for treating nervous system disorders. The composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke and kelp. Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum. [0018]
  • In a preferred embodiment, the composition is formed by preparing a mixture comprising an effective amount of beta carotene, vitamin E, selenium, vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-1, vitamin B-2, niacinamide, vitamin B-12, zinc, copper, biotin, pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, betaine HCl, pancreatin, papain, and pepsin. [0019]
  • The effective range amount of each ingredient for sixty pounds of body weight is as follows: 1,250-25,000 IU beta carotene, 25-400 IU vitamin E, 25-100 mcg selenium, 100-500 mg vitamin B-6, 400-800 mcg folic acid, 250-1,000 mg vitamin C, 125-500 mg magnesium, 12.5-50 mg vitamin B-1, 12.5-50 mg vitamin B-2, 15-60 mg niacinamide, 12.5-50 mcg vitamin B-12, 8-50 mg zinc, 250-1,000 mcg copper, 25-100 mcg biotin, 12.5-50 mg pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg betaine HCl, 125-1,000 mg pancreatin, 50-250 mg papain, and (1:3000) 15-100 mg pepsin. [0020]
  • In a preferred embodiment, the effective amount of each ingredient for sixty pounds of body weight is as follows: 5000 IU beta carotene, 50 IU vitamin E, 25 mcg selenium, 500 mg vitamin B-6, 400 mcg folic acid, 500 mg vitamin C, 250 mg magnesium, 25 mg vitamin B-1, 25 mg vitamin B-2, 30 mg niacinamide, 25 mcg vitamin B-12, 10 mg zinc, 500 mcg copper, 50 mcg biotin, 25 mg pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg betaine HCl, 250 mg pancreatin, 100 mg papain, and (1:3000) 30 mg pepsin. [0021]
  • Vitamin B-6 comprises a group of closely related compounds: pyridoxine, pyridoxal, and pyridoxamine. They are all phosphorylated in the body to pyridoxal phosphate, which functions as a coenzyme in many reactions. Vitamin B-6 helps to make and take apart many amino acids and is also needed to make serotonin, melatonin, and dopamine. Vitamin B-6 also aids in the formation of several neurotransmitters and is therefore an essential nutrient in the regulation of mental processes and possibly mood. Vitamin B-6 has been found to be helpful in almost half of all autistic children and adults included in 18 consecutive studies between 1965 and 1996. In other studies, the average amount of B6 found to be beneficial was around 8 mg of B6 per pound of body weight, per day. (This is about 500 mg/day for a 60 pound child.) B-6 is the preferred substance for this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of B-6 could be substituted. [0022]
  • Folic acid is needed to make SAMe (S-adenosyl-L-methionine), which affects and may improve mood. Folate (folic acid) deficiency has been shown to lead to many conditions including psychiatric disorders. (Merck Manual 14th edition) Folic acid itself has been reported to be helpful in autism. Folic Acid is the preferred substance for this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of Folic acid could be substituted. [0023]
  • Vitamin C is crucial to brain function and has been known to improve cognition and emotional symptoms. Vitamin C (ascorbic acid) is the preferred substance for this formulation, however other items such as Capsicum, Rose Hips, Alfalfa, Asparagus root, Barberry bark, Bilberry fruit, Celery seed, Chaparral, Cranberry fruit, Echinacea, Goldenseal, Parsley, Hops, Horseradish, Mullein leaf, Nettle leaf, Papaya fruit, Peppermint, Red Clover, Red Raspberry, and Yellow Dock also have high concentrations of Vitamin C could be substituted. [0024]
  • Magnesium has been found to enhance the effects of B-6 and protect against possible magnesium deficiency from processed foods. Magnesium has been known to reduce hyperactivity in children. Other research suggests that some children with ADD have lowered levels of magnesium. Magnesium is the preferred substance for this formulation, however other items such as Althea root, Astragalus root, Bilberry fruit, Irish moss, Boneset, Bupleururn root, Burdock root, Catnip, Chamomile, Chickweed, Devil's Claw, Elecampane root, Fennel seed, Ginger root, Gotu Kola, Hibiscus flower, Horseradish root, Horsetail, Hydrangea root, Kelp, Licorice root, Nettle, Oatgrass, Parsley, Peppermint, Red Raspberry leaf, Siberian Ginseng, Spirulina, Turneric, White Willow bark, and Yerba Santa also have high concentrations of Magnesium could be substituted. [0025]
  • Vitamin B-3 comes in two basic forms—niacin (also called nicotinic acid) and niacinamide (also called nicotinamide). The body uses B-3 in the process of releasing energy from carbohydrates. It is needed to form fat from carbohydrates and to process alcohol. Deficiencies of B-3 include symptoms of organic psychosis, characterized by memory impairment, disorientation, confusion, excitement, depression and mania. It also can lead to encephalopathic syndrome, characterized by clouding of consciousness, rigidity of the extremities and uncontrollable sucking and grasping reflexes. Niacinamide is the preferred substance for use in this formulation, however other items such as Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina also have high concentrations of niacin could be substituted. [0026]
  • Copper is essential as a catalyst in many of the enzymatic pathways in the body. It is also part of the antioxidant enzyme superoxide dismutase (SOD). Copper is needed to make adenosine triphosphate (ATP), the energy on which the body runs. Copper is the preferred substance for this formulation, however other items such as Scullcap, Sage, White oak bark, Horsetail, Brewer's yeast also have high concentrations of Copper could be substituted. [0027]
  • Dandelion Root supports the digestive tract. It primarily works with the liver and gallbladder by stimulating digestive enzymes produced by each organ. It also stimulates digestion and can help with those who suffer from constipation and acid reflux. This herb is also high in many vitamins and minerals. Vitamins found in food are better absorbed and retained by the body. This is essential to the formulation by not only giving the digestive system support, but also by giving a natural source of vitamins and minerals. Dandelion is the preferred substance for use in this formulation, however other items such as Kelp, Sea Vegetation, Alfalfa, Trace Minerals, and Molybdenum, which also have high concentrations of minerals, could be substituted. As for digestive support, Dandelion is the preferred substance for use in this formulation, however other items such as Juniper, Aloe vera, Burdock, Ginger root, and Artichoke also have potent effects on supporting the digestive tract and could be substituted. [0028]
  • Probiotic (acidophilus dairy free/bifidus dairy free) bacteria favorably alter the intestinal micro-flora balance, inhibit the growth of harmful bacteria, promote good digestion, boost immune function, and increase resistance to infection. Individuals with flourishing intestinal colonies of beneficial bacteria are better equipped to fight the growth of disease-causing bacteria. Probiotics are important in finishing the digestive process and therefore can increase the absorption of nutrients. [0029]
  • Fructo-oligosaccharides (FOS) are naturally occurring carbohydrates that cannot be digested or absorbed by humans but support the growth of bifidobacteria, one of the beneficial bacterial strains. Friendly bacteria support digestion, elimination and the absorption of nutrients in the body. [0030]
  • Betaine—(hcl/gastric acid) One of the most important parts of digestion occurs in the stomach, where gastric (stomach) acid helps break down proteins for further digestion in the small intestine. This increased digestion aids in the absorption of nutrients that support the nervous system. [0031]
  • Papain/Pancreatin/Pepsin—Digestive enzymes—also called pancreatic enzymes—include three classes of enzymes: proteolytic enzymes needed to digest protein, lipases needed to digest fat, and amylases needed to digest carbohydrates. Pancreatic enzymes should be used with to support the digestive process. Allergies are triggered by partially undigested protein, while protoolytic enzymes reduce allergy symptoms. Proteolytic enzymes such as trypsin, chymotrypsin, and bromelain are partially absorbed by the body. Proteolytic enzymes may improve immune system ftinction, a common problem with people with allergies and nervous system weakness. Papain, Pancreatin and, Pepsin are the preferred substance for this formulation, however other items such as Papaya, and Pineapple also have high concentrations of these digestive enzymes could be substituted. [0032]
  • Vitamin B-1 is needed to process carbohydrates, fat, and protein. Vitamin B-1 aids in the formation of ATP. Nerve cells require vitamin B-1 in order to function normally. [0033]
  • Vitamin B-2 is needed to process amino acids and fats, activate Vitamin B-6 and folic acid and help convert carbohydrates into ATP. Vitamin B-2 can also act as an antioxidant. [0034]
  • Vitamin B-12 is needed for normal nerve cell activity, DNA replication, and production of the mood-affecting substance SAMe (S-adenosyl-L-methionine). Vitamin B-12 acts with folic acid and vitamin B-6 to control homocysteine levels. An excess of homocysteine may increase the risk of heart disease, stroke, and perhaps osteoporosis and Alzheimer's disease. [0035]
  • Biotin, a water-soluble B vitamin, acts as a coenzyme during the metabolism of protein, fats, and carbohydrates. Certain rare inborn diseases can leave people with depletion of biotin due to the inability to metabolize the vitamin normally. [0036]
  • Pantothenic acid, sometimes called vitamin B-5, is involved in the Kreb's cycle of energy production and is needed to make the neurotransmitter acetylcholine. It is also essential in producing, transporting, and releasing energy from fats. Synthesis of cholesterol (needed for vitamin D and hormone synthesis) depends on pantothenic acid. Pantothenic acid also activates the adrenal glands. Pantethine—a variation of pantothenic acid—has been reported to lower blood levels of cholesterol and triglycerides. [0037]
  • Chromium Polynicotinate supports the balancing of blood sugar levels. Fast peaks and valley's of blood sugar have been linked to behavioral changes in humans. Chromium is the preferred substance for this formulation, however other items such as Hibiscus flower, Spirulina, Gymnema, Oatstraw, Nettle, Red Clover, Stevia, Barley Grass, Horseradish, Juniper, Pollen, Red Clover, Brewer's Yeast, Ginkgo, Catnip, also have high concentrations of Chromium could be substituted. [0038]
  • Beta-carotene (Vitamin A), by maintaining healthy cell membranes, helps prevent invasion by disease-causing microorganisms. Vitamin A also stimulates immunity and is needed for formation of bone, protein, and growth hormone. Beta-carotene is a substance from plants that the body can convert to vitamin A. There is research linking vitamin A deficiency to humans with Autism and other mental health and behavioral challenges. Beta-carotene is the preferred substance for this formulation, however other items such as Spirulina, Carrot, Gotu Kola, cabbage, Barley grass, Peppermint, Yellow Dock, Parsley, Horseradish, Alfalfa, Chaparral, Capsicum, Blessed Thistle, Nettle, Yerba santa, Dandelion and Stevia also have high concentrations of Beta-carotene (Vitamin A) could be substituted.[0039]
    • EXAMPLE
  • A sample composition, for a patient weighing sixty pounds, according to the present invention is set forth below: [0040]
    INGREDIENT AMOUNT
    Beta Carotene 5000 IU
    Vitamin E 50 IU
    Selenium 25 mcg
    Vitamin B-6 500 mg
    Folic Acid 400 mcg
    Vitamin C 500 mg
    Magnesium 250 mg
    Vitamin B-1 25 mg
    Vitamin B-2 25 mg
    Niacinamide 30 mg
    Vitamin B-12 25 mcg
    Zinc 10 mg
    Copper 500 mcg
    Biotin 50 mcg
    Pantothenic acid 25 mg
    Dandelion root 250 mg
    Acidophilus dairy free 500 million cfu
    bifidus dairy free 500 million cfu
    FOS powder 250 mg
    Chromium 100 mcg
    polynicotinate
    Betaine HCL 30 mg
    Pancreatin 250 mg
    Papain 100 mg
    Pepsin (1:3000) 30 mg
  • It has been found that this composition is useful in treating various nervous system disorders, without adverse side effects. Many improvements, modifications, and additions will be apparent to the skilled artisan without departing from the spirit and scope of the present invention as described herein and defined in the following claims.[0041]

Claims (20)

What is claimed is:
1. A composition for the treatment of nervous system disorders, comprising therapeutically effective amounts of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide, betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp.
2. A composition for the treatment of nervous system disorders as in claim 1, wherein said digestive support ingredient is dandelion root.
3. A composition for the treatment of nervous system disorders as in claim 1, wherein said probiotics are acidophilus dairy-free and bifidus dairy-free.
4. A composition for the treatment of nervous system disorders as in claim 1, wherein vitamin B-3 is in the form of niacinamide.
5. A composition for the treatment of nervous system disorders as in claim 1, wherein said vitamin B-6 is derived from one or more of the items selected from the group consisting of Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina.
6. A composition for the treatment of nervous system disorders as in claim 1, wherein said folic acid is derived from one or more of the items selected from the group consisting of Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina
7. A composition for the treatment of nervous system disorders as in claim 1, wherein said vitamin C is derived from one or more of the items selected from the group consisting of Capsicum, Rose Hips, Alfalfa, Asparagus root, Barberry bark, Bilberry fruit, Celery seed, Chaparral, Cranberry fruit, Echinacea, Goldenseal, Parsley, Hops, Horseradish, Mullein leaf, Nettle leaf, Papaya fruit, Peppermint, Red Clover, Red Raspberry, and Yellow Dock.
8. A composition for the treatment of nervous system disorders as in claim 1, wherein said magnesium is derived from one or more of the items selected from the group consisting of Althea root, Astragalus root, Bilberry fruit, Irish moss, Boneset, Bupleururn root, Burdock root, Catnip, Chamomile, Chickweed, Devil's Claw, Elecampane root, Fennel seed, Ginger root, Gotu Kola, Hibiscus flower, Horseradish root, Horsetail, Hydrangea root, Kelp, Licorice root, Nettle, Oatgrass, Parsley, Peppermint, Red Raspberry leaf, Siberian Ginseng, Spirulina, Turneric, White Willow bark, and Yerba Santa.
9. A composition for the treatment of nervous system disorders as in claim 1, wherein said vitamin B-3 is derived from one or more of the items selected from the group consisting of Gotu kola, Capsicum, Alfalfa, Asparagus root, Barberry bark, Blue Cohosh, Boneset, Butcher's Broom, Chamomile, Parsley, Feverfew, Ginkgo biloba, Hops, Hydrangea root, Peppermint, Pollen, Red Clover, Red Raspberry, Rose Hips, Siberian Ginseng, Slippery Elm bark, and Spirulina.
10. A composition for the treatment of nervous system disorders as in claim 1, wherein said copper is derived from one or more of the items selected from the group consisting of Scullcap, Sage, White oak bark, Horsetail, and Brewer's yeast.
11. A composition for the treatment of nervous system disorders as in claim 1, wherein said chromium polynicotinate is derived from one or more of the items selected from the group consisting of Hibiscus flower, Spirulina, Gymnema, Oatstraw, Nettle, Red Clover, Stevia, Barley Grass, Horseradish, Juniper, Pollen, Red Clover, Brewer's Yeast, Ginkgo, and Catnip.
12. A composition for the treatment of nervous system disorders as in claim 1, wherein said composition also comprises: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.
13. A composition for the treatment of nervous system disorders, comprising therapeutically effective amounts of Beta Carotene, Vitamin E, Selenium, Vitamin B-6, Folic Acid, Vitamin C, Magnesium, Vitamin B-1, Vitamin B-2, Niacinamide, Vitamin B-12, Zinc, Copper, Biotin, Pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, Betaine HCL, Pancreatin, Papain, and Pepsin.
14. A composition for the treatment of nervous system disorders as in claim 13, based on sixty pounds of body weight, wherein said effective amount comprises 1,250-25,000 IU Beta Carotene, 25-400 IU Vitamin E, 25-100 mcg Selenium, 100-500 mg Vitamin B-6, 400-800 mcg Folic Acid, 250-1,000 mg Vitamin C, 125-500 mg Magnesium, 12.5-50 mg Vitamin B-1, 12.5-50 mg Vitamin B-2, 15-60 mg Niacinamide, 12.5-50 mcg Vitamin B-12, 8-50 mg Zinc, 250-1,000 mcg Copper, 25-100 mcg Biotin, 12.5-50 mg Pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg Betaine HCL, 125-1,000 mg Pancreatin, 50-250 mg Papain, and (1:3000) 15-100 mg Pepsin.
15. A composition for the treatment of nervous system disorders as in claim 14, based on sixty pounds of body weight, wherein said effective amount is 5000 IU Beta Carotene, 50 IU Vitamin E, 25 mcg Selenium, 500 mg Vitamin B-6, 400 mcg Folic Acid, 500 mg Vitamin C, 250 mg Magnesium, 25 mg Vitamin B-1, 25 mg Vitamin B-2, 30 mg Niacinamide, 25 mcg Vitamin B-12, 10 mg Zinc, 500 mcg Copper, 50 mcg Biotin, 25 mg Pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg Betaine HCL, 250 mg Pancreatin, 100 mg Papain, and (1:3000) 30 mg Pepsin.
16. A treatment for nervous system disorders as in claim 1, wherein said composition is in the form of a capsule, tablet or powder.
17. A method for treating nervous system disorders comprised of the administration to a patient in need thereof an effective amount of a composition comprising: therapeutically effective amounts of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide, betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, kelp, sea vegetation, alfalfa, trace minerals and molybdenum.
18. A method for treating nervous system disorders comprised of the administration to a patient in need thereof an effective amount of a composition comprising: therapeutically effective amounts of Beta Carotene, Vitamin E, Selenium, Vitamin B-6, Folic Acid, Vitamin C, Magnesium, Vitamin B-1, Vitamin B-2, Niacinamide, Vitamin B-12, Zinc, Copper, Biotin, Pantothenic acid, dandelion root, acidophilus dairy free, bifidus dairy free, FOS powder, chromium polynicotinate, Betaine HCL, Pancreatin, Papain, and Pepsin.
19. A method for treating nervous system disorders as in claim 18, based on administration to a patient with sixty pounds of body weight, wherein said effective amount comprises 1,250-25,000 IU Beta Carotene, 25-400 IU Vitamin E, 25-100 mcg Selenium, 100-500 mg Vitamin B-6, 400-800 mcg Folic Acid, 250-1,000 mg Vitamin C, 125-500 mg Magnesium, 12.5-50 mg Vitamin B-1, 12.5-50 mg Vitamin B-2, 15-60 mg Niacinamide, 12.5-50 mcg Vitamin B-12, 8-50 mg Zinc, 250-1,000 mcg Copper, 25-100 mcg Biotin, 12.5-50 mg Pantothenic acid, 250-2,000 mg dandelion root, 500-3,000 million cfu acidophilus dairy free, 500-3,000 million cfu bifidus dairy free, 250-500 mg FOS powder, 100-200 mcg chromium polynicotinate, 15-100 mg Betaine HCL, 125-1,000 mg Pancreatin, 50-250 mg Papain, and (1:3000) 15-100 mg Pepsin.
20. A method for treating nervous system disorders as in claim 19, based on administration to a patient with sixty pounds of body weight, wherein said effective amount is 5000 IU Beta Carotene, 50 IU Vitamin E, 25 mcg Selenium, 500 mg Vitamin B-6, 400 mcg Folic Acid, 500 mg Vitamin C, 250 mg Magnesium, 25 mg Vitamin B-1, 25 mg Vitamin B-2, 30 mg Niacinamide, 25 mcg Vitamin B-12, 10 mg Zinc, 500 mcg Copper, 50 mcg Biotin, 25 mg Pantothenic acid, 250 mg dandelion root, 500 million cfu acidophilus dairy free, 500 million cfu bifidus dairy free, 250 mg FOS powder, 100 mcg chromium polynicotinate, 30 mg Betaine HCL, 250 mg Pancreatin, 100 mg Papain, and (1:3000) 30 mg Pepsin.
US09/865,040 2000-05-26 2001-05-24 Nutritional system for nervous system disorders Expired - Fee Related US6399114B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/865,040 US6399114B2 (en) 2000-05-26 2001-05-24 Nutritional system for nervous system disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20766500P 2000-05-26 2000-05-26
US09/865,040 US6399114B2 (en) 2000-05-26 2001-05-24 Nutritional system for nervous system disorders

Publications (2)

Publication Number Publication Date
US20020001575A1 true US20020001575A1 (en) 2002-01-03
US6399114B2 US6399114B2 (en) 2002-06-04

Family

ID=26902455

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/865,040 Expired - Fee Related US6399114B2 (en) 2000-05-26 2001-05-24 Nutritional system for nervous system disorders

Country Status (1)

Country Link
US (1) US6399114B2 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919330B2 (en) 2002-02-07 2005-07-19 Laxdale Limited Formulations of drugs
EP1607096A2 (en) * 2004-06-18 2005-12-21 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
US20060024391A1 (en) * 2004-07-30 2006-02-02 Lak Zarahmehran S Dietary nutritional suppliments for persons smoking tobacco products
JP2006104157A (en) * 2004-10-07 2006-04-20 Dai Ichi Seiyaku Co Ltd Psychotropic drug
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US20080031860A1 (en) * 2003-12-24 2008-02-07 N.V. Nutricia Compositions Comprising Pantothenic Acid or Derivatives Thereof and Their Use for Stimulating Appetite
US20080166334A1 (en) * 2004-09-28 2008-07-10 Fallon Joan M Combination enzyme for cystic fibrosis
US20090004147A1 (en) * 2007-06-28 2009-01-01 Gorsek Wayne F Composition for a healthy gastrointestinal tract
US20090324572A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of williams syndrome
US20100169409A1 (en) * 2008-08-04 2010-07-01 Fallon Joan M Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of parkinsons disease, movement and neurological disorders, and chronic pain
US20110182818A1 (en) * 2008-07-01 2011-07-28 Fallon Joan M Methods and compositions for the treatment of symptoms of neurological and mental health disorders
CN103127286A (en) * 2011-12-05 2013-06-05 鲍力恒 Medicine component used for curing or lightening melancholia or neurodegeneration disease
WO2013103746A1 (en) * 2012-01-03 2013-07-11 Curemark, Llc Methods of treating behavioral symptoms of neurological and mental disorders
US8486390B2 (en) 2008-04-18 2013-07-16 Curemark Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US8580522B2 (en) 2000-11-16 2013-11-12 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8613918B2 (en) 1999-12-17 2013-12-24 Curemark Llc Method for treating pervasive development disorders
US8673877B2 (en) 2005-08-30 2014-03-18 Curemark, Llc Use of lactulose in the treatment of autism
CN103690445A (en) * 2013-12-25 2014-04-02 丘少荣 Fresh and cool day cream and preparation method
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
US9023344B2 (en) 2008-03-13 2015-05-05 Curemark, Llc Method of treating toxemia
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9061033B2 (en) 2008-10-03 2015-06-23 Curemark Llc Methods and compositions for the treatment of symptoms of prion diseases
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
CN110916192A (en) * 2019-11-25 2020-03-27 垒途智能教科技术研究院江苏有限公司 Probiotic mineral powder capable of preventing and treating autism of children and teenagers and application thereof
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043507A2 (en) * 2000-11-30 2002-06-06 The Health Research Institute Nutrient supplements and methods for treating autism and for preventing the onset of autism
US6660262B2 (en) * 2001-09-28 2003-12-09 Bovine Health Products, Inc. Broad spectrum antimicrobial compound and treatment
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050158404A1 (en) * 2003-11-18 2005-07-21 Goodless Dean R. Composition and method for treatment of acne
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
US7112343B1 (en) 2004-05-24 2006-09-26 Robbie Shoemake Immune system reconstructor composition
US20060024327A1 (en) * 2004-07-30 2006-02-02 Chuang-Chun Chiueh Composition for controlling blood sugar
US20060105063A1 (en) * 2004-11-18 2006-05-18 Kent Hann Synergic combination of compositions containing aloe vera isolates and their therapeutic application
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
MA29706B1 (en) * 2007-02-14 2008-09-01 Philippe Alleon FOOD SUPPLEMENT COMPRISING SPIRULINA AND A PLANT PRODUCT OF THE GENUS ALOE, AND COSMETIC USE THEREOF
US8652545B2 (en) * 2008-02-13 2014-02-18 Reverta Health Solutions LLC Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children
US20090232915A1 (en) * 2008-03-14 2009-09-17 Symrise Gmbh & Co., Kg Mixtures with a collagen synthesis boosting action
US8658225B2 (en) * 2008-12-31 2014-02-25 Znova, Llc Herbal-based nasal solution and method of use thereof
WO2012050895A1 (en) 2010-09-28 2012-04-19 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US9931365B2 (en) 2010-09-28 2018-04-03 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US11096904B2 (en) * 2018-05-11 2021-08-24 Linda J. Kaplan Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432975A (en) * 1981-04-13 1984-02-21 Icn Pharmaceuticals, Inc. Process for introducing vitamin B-12 into the bloodstream
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
JP2654529B2 (en) * 1992-03-27 1997-09-17 大塚製薬株式会社 Health drink composition
US5567424A (en) * 1994-06-10 1996-10-22 Reliv International, Inc. Fiber, antioxidant, herbal and enzyme supplemented beverage composition for human consumption
US5569458A (en) * 1994-09-14 1996-10-29 Greenberg; Mike Nutritional formula
US5730988A (en) * 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
US5877171A (en) * 1997-07-28 1999-03-02 Mcleod; Malcolm N. Method of treating pre-menstrual syndrome using chromium
US5902797A (en) * 1997-11-10 1999-05-11 Beth Israel Deaconess Medical Center Nutritional supplement for use in the treatment of attention deficit
US5905075A (en) * 1998-08-28 1999-05-18 Ambi Inc. Chromium nicotinate compositions and uses thereof

Cited By (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8613918B2 (en) 1999-12-17 2013-12-24 Curemark Llc Method for treating pervasive development disorders
US8815233B2 (en) 1999-12-17 2014-08-26 Curemark Llc Method for treating pervasive development disorders
US9624525B2 (en) 1999-12-17 2017-04-18 Curemark, Llc Method for treating pervasive development disorders
US9624526B2 (en) 1999-12-17 2017-04-18 Curemark Llc Method for treating pervasive development disorders
US20080152637A1 (en) * 2000-08-14 2008-06-26 Fallon Joan M Methods of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8778335B2 (en) 2000-08-14 2014-07-15 Curemark, Llc Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US9233146B2 (en) 2000-08-14 2016-01-12 Curemark, Llc Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders
US9377459B2 (en) 2000-11-16 2016-06-28 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8921054B2 (en) 2000-11-16 2014-12-30 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US10209253B2 (en) 2000-11-16 2019-02-19 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8580522B2 (en) 2000-11-16 2013-11-12 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US6919330B2 (en) 2002-02-07 2005-07-19 Laxdale Limited Formulations of drugs
US20080031860A1 (en) * 2003-12-24 2008-02-07 N.V. Nutricia Compositions Comprising Pantothenic Acid or Derivatives Thereof and Their Use for Stimulating Appetite
US8388949B2 (en) * 2003-12-24 2013-03-05 N.V. Nutricia Compositions comprising pantothenic acid and their use for stimulating appetite
EP1607096A3 (en) * 2004-06-18 2006-01-04 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
EP1607096A2 (en) * 2004-06-18 2005-12-21 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
US20060024391A1 (en) * 2004-07-30 2006-02-02 Lak Zarahmehran S Dietary nutritional suppliments for persons smoking tobacco products
US20080166334A1 (en) * 2004-09-28 2008-07-10 Fallon Joan M Combination enzyme for cystic fibrosis
US20100233218A1 (en) * 2004-09-28 2010-09-16 Curemark Llc Combination enzyme for cystic fibrosis
JP2006104157A (en) * 2004-10-07 2006-04-20 Dai Ichi Seiyaku Co Ltd Psychotropic drug
US10350229B2 (en) 2005-08-30 2019-07-16 Curemark, Llc Use of lactulose in the treatment of autism
US8673877B2 (en) 2005-08-30 2014-03-18 Curemark, Llc Use of lactulose in the treatment of autism
US11033563B2 (en) 2005-08-30 2021-06-15 Curemark, Llc Use of lactulose in the treatment of autism
US9345721B2 (en) 2005-08-30 2016-05-24 Curemark, Llc Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US20090004147A1 (en) * 2007-06-28 2009-01-01 Gorsek Wayne F Composition for a healthy gastrointestinal tract
US9925250B2 (en) 2008-03-13 2018-03-27 Curemark, Llc Method of treating proteinuria in pregnancy
US9023344B2 (en) 2008-03-13 2015-05-05 Curemark, Llc Method of treating toxemia
US9408895B2 (en) 2008-03-13 2016-08-09 Curemark, Llc Method of treating pregnancy-induced hypertension
US11045527B2 (en) 2008-03-13 2021-06-29 Curemark, Llc Method of diagnosing preeclampsia or pregnancy-induced hypertension
US10272141B2 (en) 2008-04-18 2019-04-30 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US9687534B2 (en) 2008-04-18 2017-06-27 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US8486390B2 (en) 2008-04-18 2013-07-16 Curemark Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US9017665B2 (en) 2008-04-18 2015-04-28 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US11235038B2 (en) 2008-04-18 2022-02-01 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US10588948B2 (en) 2008-06-26 2020-03-17 Curemark, Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20090324572A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of williams syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20110182818A1 (en) * 2008-07-01 2011-07-28 Fallon Joan M Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100169409A1 (en) * 2008-08-04 2010-07-01 Fallon Joan M Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of parkinsons disease, movement and neurological disorders, and chronic pain
US10413601B2 (en) 2008-10-03 2019-09-17 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US9061033B2 (en) 2008-10-03 2015-06-23 Curemark Llc Methods and compositions for the treatment of symptoms of prion diseases
US9687535B2 (en) 2008-10-03 2017-06-27 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US11357835B2 (en) 2009-01-06 2022-06-14 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US10736946B2 (en) 2009-01-06 2020-08-11 Galenagen, Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9895427B2 (en) 2009-01-06 2018-02-20 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US11419821B2 (en) 2009-04-13 2022-08-23 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9931302B2 (en) 2009-04-13 2018-04-03 Curemark , LLC Enzyme delivery systems and methods of preparation and use
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US10098844B2 (en) 2009-04-13 2018-10-16 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9415014B2 (en) 2009-04-13 2016-08-16 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US10716835B2 (en) 2009-10-21 2020-07-21 Curemark, Llc Methods and compositions for the prevention and treatment of influenza
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
US10279016B2 (en) 2011-04-21 2019-05-07 Curemark, Llc Method of treatment of schizophreniform disorder
US10940187B2 (en) 2011-04-21 2021-03-09 Curemark, Llc Method of treatment of schizophreniform disorder
US9492515B2 (en) 2011-04-21 2016-11-15 Curemark, Llc Method of treatment of schizophreniform disorder
CN103127286A (en) * 2011-12-05 2013-06-05 鲍力恒 Medicine component used for curing or lightening melancholia or neurodegeneration disease
CN108578684A (en) * 2012-01-03 2018-09-28 柯尔马克有限责任公司 The method for the treatment of nerve and the behavior symptom of phrenoblabia
RU2654230C2 (en) * 2012-01-03 2018-05-17 КЬЮАМАРК, ЮЭс ЭлЭлСи Methods of treating behavioral symptoms of neurological and mental disorders
JP2015503586A (en) * 2012-01-03 2015-02-02 キュアマーク リミテッド ライアビリティ カンパニー Methods for treating behavioral symptoms of neurological and psychiatric disorders
CN104144698A (en) * 2012-01-03 2014-11-12 柯尔马克有限责任公司 Methods of treating behavioral symptoms of neurological and mental disorders
WO2013103746A1 (en) * 2012-01-03 2013-07-11 Curemark, Llc Methods of treating behavioral symptoms of neurological and mental disorders
JP2019006788A (en) * 2012-01-03 2019-01-17 キュアマーク リミテッド ライアビリティ カンパニー Methods of treating behavioral symptoms of neurological and mental disorders
JP2021001222A (en) * 2012-01-03 2021-01-07 キュアマーク， リミテッド ライアビリティ カンパニー Methods of treating behavioral symptoms of neurological and mental disorders
GB2511713B (en) * 2012-01-03 2020-03-04 Curemark Llc Compositions for the treatment of bone fragility
AU2013206890B2 (en) * 2012-01-03 2017-09-28 Curemark, Llc Methods of treating behavioral symptoms of neurological and mental disorders
GB2511713A (en) * 2012-01-03 2014-09-10 Curemark Llc Methods of treating behavioral symptoms of neurological and mental disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11364287B2 (en) 2012-05-30 2022-06-21 Curemark, Llc Methods of treating celiac disease
CN103690445A (en) * 2013-12-25 2014-04-02 丘少荣 Fresh and cool day cream and preparation method
CN103690445B (en) * 2013-12-25 2016-05-04 丘少荣 A kind of salubrious day cream and preparation method
CN110916192A (en) * 2019-11-25 2020-03-27 垒途智能教科技术研究院江苏有限公司 Probiotic mineral powder capable of preventing and treating autism of children and teenagers and application thereof
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Also Published As

Publication number Publication date
US6399114B2 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
US6399114B2 (en) Nutritional system for nervous system disorders
US11351206B2 (en) Probiotic sports nutrition compositions
US9180148B2 (en) Metallo-lactoferrin-coenzyme compositions and methods for weight management
KR101938865B1 (en) Composition for preventing or treating bone disease, obesity and lipid-related metabolic disease
US4973467A (en) Dietary supplement for adults
US10842839B2 (en) Natural formulation for treating hangover
CN101248873A (en) Drinking food product with sight protection function
US20140335130A1 (en) Amino acid supplementation for a healthy microbiota ecosystem
KR20050088994A (en) Antioxidative composition
CN101428037B (en) Anti-apolexis composition containing repair factor
NO20001717L (en) Serotonin-containing formulation for oral administration and use of the same
US20100015259A1 (en) Composition and method for improving human concentration, memory and other cognitive brain
CN102499939B (en) Pharmaceutical compositions of fat-soluble vitamins for injection and water-soluble vitamins for injection and preparation method thereof
JP2005312424A (en) Method for producing fermented product using kefir grain, and fermented product obtained by the same
CN103169756A (en) Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamin injection and fat emulsion injection
CN103169755B (en) Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamins for injection and fat emulsion injection
CN107510701B (en) A kind of children mend the composition and its preparation method and application of iron and vitamin
US20070031487A1 (en) Nutritional supplement for women
RU2751190C1 (en) Anti-stress drink
WO2022091023A1 (en) Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system
EP3441062A1 (en) Seawater and salt powder balancing formulations and nutritional and pharmaceutical compositions
WO2015118363A1 (en) Food supplement comprising l-tryptophan and vitamin b
US20230139125A1 (en) Dietary supplement for improving brain performance
UA141618U (en) PREPARATION OF PROBIOTIC ACTION IN THE FORM OF CAPSULES
CN115702661A (en) Nutritional supplement with fatigue relieving function and preparation method and application thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: C&D FOREMAN, INC., VIRGINIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FOREMAN, DAVID J.;REEL/FRAME:011844/0064

Effective date: 20010523

FEPP Fee payment procedure

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20100604